|
|
BSE |
NSE |
|
|
Products & Services > Company Profile > Balance Sheet |
|
| Astrazeneca Pharma India Ltd | Industry : Pharmaceuticals - Multinational | BSE Code: | 506820 | | NSE Symbol: | ASTRAZEN | | P/E : | 83.6 | ISIN Demat: | INE203A01020 | | Div & Yield %: | 0.3 | | EPS : | 63.8 | Book Value: | 261.98604 | | Market Cap (Rs.Cr): | 13334.63 | | Face Value : | 2 | |
|
(Rs. In Crores) |
|
| | | | | | Share Capital | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | Reserves Total | 583.69 | 506.39 | 451.17 | 359.44 | 295.80 | 241.93 | Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Total Shareholders Funds | 588.69 | 511.39 | 456.17 | 364.44 | 300.80 | 246.93 | Secured Loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Unsecured Loans | 7.21 | 8.63 | 12.14 | 11.84 | 0.00 | 0.00 | Total Debt | 7.21 | 8.63 | 12.14 | 11.84 | 0.00 | 0.00 | Other Liabilities | 8.56 | 7.50 | 6.41 | 5.38 | 2.02 | 6.66 | Total Liabilities | 604.46 | 527.52 | 474.72 | 381.66 | 302.82 | 253.59 | | | | | | | Gross Block | 179.12 | 168.83 | 159.78 | 132.84 | 119.83 | 105.85 | Less : Accumulated Depreciation | 110.26 | 94.34 | 78.82 | 61.31 | 45.00 | 30.39 | Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Block | 68.86 | 74.49 | 80.96 | 71.53 | 74.83 | 75.46 | Lease Adjustment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Capital Work in Progress | 1.33 | 2.20 | 4.02 | 24.24 | 6.90 | 3.57 | Producing Properties | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Current Assets, Loans & Advances | | | | | | | Inventories | 190.21 | 140.22 | 159.80 | 165.15 | 118.10 | 113.15 | Sundry Debtors | 107.52 | 85.89 | 85.19 | 83.21 | 79.75 | 54.63 | Cash and Bank Balance | 500.48 | 448.46 | 352.35 | 252.52 | 173.30 | 125.92 | Loans and Advances | 37.26 | 31.10 | 21.42 | 41.44 | 33.57 | 27.22 | Total Current Assets | 835.47 | 705.67 | 618.76 | 542.32 | 404.72 | 320.92 | Less : Current Liabilities and Provisions | | | | | | | Current Liabilities | 336.31 | 281.06 | 257.44 | 278.24 | 222.58 | 166.61 | Provisions | 44.10 | 47.98 | 42.55 | 46.46 | 36.40 | 40.34 | Total Current Liabilities & Provisions | 380.41 | 329.04 | 299.99 | 324.70 | 258.98 | 206.95 | Net Current Assets | 455.06 | 376.63 | 318.77 | 217.62 | 145.74 | 113.97 | Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Deferred Tax Assets | 22.20 | 18.17 | 17.31 | 17.47 | 24.42 | 34.32 | Deferred Tax Liability | 1.53 | 1.87 | 2.78 | 2.83 | 1.06 | 1.77 | Net Deferred Tax | 20.67 | 16.30 | 14.53 | 14.64 | 23.36 | 32.55 | Other Assets | 58.54 | 57.90 | 56.44 | 53.63 | 51.99 | 28.04 | Total Assets | 604.46 | 527.52 | 474.72 | 381.66 | 302.82 | 253.59 | Contingent Liabilities | 130.25 | 121.37 | 85.66 | 67.33 | 26.77 | 7.34 |
|
|
|
|
|
|